Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationStem Cell TransplantationTransplantation, AutologousTransplantation, HomologousStem CellsTransplantation ConditioningHematopoietic Stem Cell MobilizationGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem CellsBone Marrow TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisGraft SurvivalAntigens, CD34Treatment OutcomeCord Blood Stem Cell TransplantationMelphalanTissue DonorsTransplantation ChimeraBlood Component RemovalCombined Modality TherapyBusulfanMultiple MyelomaMyeloablative AgonistsLiver TransplantationCyclophosphamideMesenchymal Stem Cell TransplantationRecurrenceAntineoplastic Combined Chemotherapy ProtocolsRemission InductionHistocompatibility TestingWhole-Body IrradiationHistocompatibilityAdult Stem CellsRetrospective StudiesImmunosuppressive AgentsCell TransplantationLymphoma, Non-HodgkinKidney TransplantationLeukemiaEmbryonic Stem CellsDisease-Free SurvivalTime FactorsVidarabineBlood CellsSurvival RateEtoposideGraft vs Leukemia EffectHematopoiesisSalvage TherapySurvival AnalysisPluripotent Stem CellsThiotepaLeukemia, Myeloid, AcuteTransplantation, IsogeneicBlood Cell CountAntineoplastic Agents, AlkylatingCell DifferentiationTransplantation ImmunologyFlow CytometryNeural Stem CellsStem Cell NicheLeukocytes, MononuclearCytarabineHematologic DiseasesT-LymphocytesCells, CulturedBone Marrow CellsHodgkin DiseaseMyelodysplastic SyndromesFollow-Up StudiesGraft vs Tumor EffectHLA AntigensInfectionSiblingsCell SeparationLymphocyte DepletionInduced Pluripotent Stem CellsMesenchymal Stromal CellsLymphocyte TransfusionHeart TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticCytomegalovirus InfectionsBone Marrow PurgingBone MarrowStem Cell FactorVincristineImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaLung TransplantationImmunophenotypingAntilymphocyte SerumMultipotent Stem CellsChimerismAcute DiseaseGraft RejectionBlood Donors